← FDA DRUG APPROVALS

FDA ANDA · ANDA212984

TESTOSTERONE GEL, 1%

Sponsor: ENCUBE

APPLICATION
ANDA212984
TYPE
ANDA
ORIGINAL APPROVAL
2021-11-09
LATEST ACTION
2025-12-17
ROUTE
TRANSDERMAL
DOSAGE FORM
GEL, GEL, METERED
MARKETING STATUS
Prescription

Products

TESTOSTERONEPrescription
TESTOSTERONE 25MG/2.5GM PACKET · GEL · TRANSDERMAL
TESTOSTERONEPrescription
TESTOSTERONE 50MG/5GM PACKET · GEL · TRANSDERMAL
TESTOSTERONEPrescription
TESTOSTERONE 12.5MG/1.25GM ACTUATION · GEL, METERED · TRANSDERMAL

Approval history

2025-12-17Labeling · Supplement 10 · standardAP
2021-11-09UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →